Psoriasis and Atopic Dermatitis Drugs Market Report

China Psoriasis and Atopic Dermatitis Drugs Industry Market Research Report 2023-2029

  • POSTDATE：Aug 20, 2023
  • PAGES：206
  • REPORT CODE：GMM1744744
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Psoriasis and Atopic Dermatitis Drugs industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Allergan Plc

    • Regeneron Pharmaceuticals, Inc

    • Leo Pharma

    • Incyte

    • Pfizer

    • Valent Pharmaceutical Inc

    • Mylan

    • Bristol-Myers Squibb Company

    • Sanofi

    • Bayer AG

    • Novartis International AG

    • Anacor Pharmaceutical Inc

    • Encore Dermatology

    By Type:

    • Psoriasis Drugs

    • Atopic Dermatitis Drugs

    By Application:

    • Online Pharmacies

    • Hospital Pharmacies

    • Retail Pharmacies

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Psoriasis and Atopic Dermatitis Drugs Market Overview 2018-2029

    • 1.1 China Psoriasis and Atopic Dermatitis Drugs Industry Development Overview

    • 1.2 China Psoriasis and Atopic Dermatitis Drugs Industry Development History

    • 1.3 China Psoriasis and Atopic Dermatitis Drugs Industry Market Size (2018-2029)

    • 1.4 China Psoriasis and Atopic Dermatitis Drugs Market Analysis by Type from Production Side

      • 1.4.1 China Psoriasis and Atopic Dermatitis Drugs Production Volume, Production Value and Growth Rate of Psoriasis Drugs (2018-2029)

      • 1.4.2 China Psoriasis and Atopic Dermatitis Drugs Production Volume, Production Value and Growth Rate of Atopic Dermatitis Drugs (2018-2029)

    • 1.5 China Psoriasis and Atopic Dermatitis Drugs Market Analysis by Application from Consumption End

      • 1.5.1 China Psoriasis and Atopic Dermatitis Drugs Sales Volume, Sales Value and Growth Rate of Online Pharmacies (2018-2029)

      • 1.5.2 China Psoriasis and Atopic Dermatitis Drugs Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)

      • 1.5.3 China Psoriasis and Atopic Dermatitis Drugs Sales Volume, Sales Value and Growth Rate of Retail Pharmacies (2018-2029)

    • 1.6 China Psoriasis and Atopic Dermatitis Drugs Market Analysis by Region

      • 1.6.1 North China Psoriasis and Atopic Dermatitis Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Psoriasis and Atopic Dermatitis Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Psoriasis and Atopic Dermatitis Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Psoriasis and Atopic Dermatitis Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Psoriasis and Atopic Dermatitis Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Psoriasis and Atopic Dermatitis Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Psoriasis and Atopic Dermatitis Drugs Market Size and Growth Rate from 2018-2029

    Chapter 2 China Psoriasis and Atopic Dermatitis Drugs Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Psoriasis and Atopic Dermatitis Drugs Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Psoriasis and Atopic Dermatitis Drugs Market Status and Competition Analysis in 2023

      • 2.2.3 China Psoriasis and Atopic Dermatitis Drugs Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Psoriasis and Atopic Dermatitis Drugs Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Psoriasis and Atopic Dermatitis Drugs Industry Development

    Chapter 3 Psoriasis and Atopic Dermatitis DrugsIndustry Chain Analysis

    • 3.1 Psoriasis and Atopic Dermatitis Drugs Industry Chain

    • 3.2 Psoriasis and Atopic Dermatitis Drugs Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Psoriasis and Atopic Dermatitis Drugs Market

    • 3.3 Psoriasis and Atopic Dermatitis Drugs Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Psoriasis and Atopic Dermatitis Drugs Market

    Chapter 4 China Psoriasis and Atopic Dermatitis Drugs Market, by Type

    • 4.1 China Psoriasis and Atopic Dermatitis Drugs Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Psoriasis and Atopic Dermatitis Drugs Total Production Volume and Growth Rate from Production Side

    • 4.5 China Psoriasis and Atopic Dermatitis Drugs Production Volume and Growth Rate, by Type

      • 4.5.1 China Psoriasis and Atopic Dermatitis Drugs Production Volume and Growth Rate of Psoriasis Drugs

      • 4.5.2 China Psoriasis and Atopic Dermatitis Drugs Production Volume and Growth Rate of Atopic Dermatitis Drugs

    Chapter 5 China Psoriasis and Atopic Dermatitis Drugs Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Psoriasis and Atopic Dermatitis Drugs Total Market Size and Growth Rate from Consumption End

    • 5.5 China Psoriasis and Atopic Dermatitis Drugs Market Size and Growth Rate, by Application

      • 5.5.1 China Psoriasis and Atopic Dermatitis Drugs Market Size and Growth Rate of Online Pharmacies

      • 5.5.2 China Psoriasis and Atopic Dermatitis Drugs Market Size and Growth Rate of Hospital Pharmacies

      • 5.5.3 China Psoriasis and Atopic Dermatitis Drugs Market Size and Growth Rate of Retail Pharmacies

    Chapter 6 China Psoriasis and Atopic Dermatitis Drugs Market, by Region

    • 6.1 China Psoriasis and Atopic Dermatitis Drugs Production Volume and Production Value, by Region

    • 6.2 China Psoriasis and Atopic Dermatitis Drugs Sales Volume and Sales Value, by Region

    Chapter 7 North China Psoriasis and Atopic Dermatitis Drugs Market Analysis

    • 7.1 North China Psoriasis and Atopic Dermatitis Drugs Market, by Type

    • 7.2 North China Psoriasis and Atopic Dermatitis Drugs Market, by Application

    Chapter 8 Central China Psoriasis and Atopic Dermatitis Drugs Market Analysis

    • 8.1 Central China Psoriasis and Atopic Dermatitis Drugs Market, by Type

    • 8.2 Central China Psoriasis and Atopic Dermatitis Drugs Market, by Application

    Chapter 9 South China Psoriasis and Atopic Dermatitis Drugs Market Analysis

    • 9.1 South China Psoriasis and Atopic Dermatitis Drugs Market, by Type

    • 9.2 South China Psoriasis and Atopic Dermatitis Drugs Market, by Application

    Chapter 10 East China Psoriasis and Atopic Dermatitis Drugs Market Analysis

    • 10.1 East China Psoriasis and Atopic Dermatitis Drugs Market, by Type

    • 10.2 East China Psoriasis and Atopic Dermatitis Drugs Market, by Application

    Chapter 11 Northeast China Psoriasis and Atopic Dermatitis Drugs Market Analysis

    • 11.1 Northeast China Psoriasis and Atopic Dermatitis Drugs Market, by Type

    • 11.2 Northeast China Psoriasis and Atopic Dermatitis Drugs Market, by Application

    Chapter 12 Southwest China Psoriasis and Atopic Dermatitis Drugs Market Analysis

    • 12.1 Southwest China Psoriasis and Atopic Dermatitis Drugs Market, by Type

    • 12.2 Southwest China Psoriasis and Atopic Dermatitis Drugs Market, by Application

    Chapter 13 Northwest China Psoriasis and Atopic Dermatitis Drugs Market Analysis

    • 13.1 Northwest China Psoriasis and Atopic Dermatitis Drugs Market, by Type

    • 13.2 Northwest China Psoriasis and Atopic Dermatitis Drugs Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Allergan Plc

        • 14.1.1 Allergan Plc Company Profile

        • 14.1.2 Allergan Plc Psoriasis and Atopic Dermatitis Drugs Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Regeneron Pharmaceuticals, Inc

        • 14.2.1 Regeneron Pharmaceuticals, Inc Company Profile

        • 14.2.2 Regeneron Pharmaceuticals, Inc Psoriasis and Atopic Dermatitis Drugs Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Leo Pharma

        • 14.3.1 Leo Pharma Company Profile

        • 14.3.2 Leo Pharma Psoriasis and Atopic Dermatitis Drugs Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Incyte

        • 14.4.1 Incyte Company Profile

        • 14.4.2 Incyte Psoriasis and Atopic Dermatitis Drugs Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Pfizer

        • 14.5.1 Pfizer Company Profile

        • 14.5.2 Pfizer Psoriasis and Atopic Dermatitis Drugs Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Valent Pharmaceutical Inc

        • 14.6.1 Valent Pharmaceutical Inc Company Profile

        • 14.6.2 Valent Pharmaceutical Inc Psoriasis and Atopic Dermatitis Drugs Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Mylan

        • 14.7.1 Mylan Company Profile

        • 14.7.2 Mylan Psoriasis and Atopic Dermatitis Drugs Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Bristol-Myers Squibb Company

        • 14.8.1 Bristol-Myers Squibb Company Company Profile

        • 14.8.2 Bristol-Myers Squibb Company Psoriasis and Atopic Dermatitis Drugs Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Sanofi

        • 14.9.1 Sanofi Company Profile

        • 14.9.2 Sanofi Psoriasis and Atopic Dermatitis Drugs Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Bayer AG

        • 14.10.1 Bayer AG Company Profile

        • 14.10.2 Bayer AG Psoriasis and Atopic Dermatitis Drugs Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Novartis International AG

        • 14.11.1 Novartis International AG Company Profile

        • 14.11.2 Novartis International AG Psoriasis and Atopic Dermatitis Drugs Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Anacor Pharmaceutical Inc

        • 14.12.1 Anacor Pharmaceutical Inc Company Profile

        • 14.12.2 Anacor Pharmaceutical Inc Psoriasis and Atopic Dermatitis Drugs Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Encore Dermatology

        • 14.13.1 Encore Dermatology Company Profile

        • 14.13.2 Encore Dermatology Psoriasis and Atopic Dermatitis Drugs Market Performance

        • 14.13.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Psoriasis and Atopic Dermatitis Drugs Industry Research Conclusions

    • 15.2 Psoriasis and Atopic Dermatitis Drugs Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Psoriasis and Atopic Dermatitis Drugs Industry Market Size (2018-2029)

    • Figure China Psoriasis and Atopic Dermatitis Drugs Production Volume, Production Value and Growth Rate of Psoriasis Drugs (2018-2029)

    • Figure China Psoriasis and Atopic Dermatitis Drugs Production Volume, Production Value and Growth Rate of Atopic Dermatitis Drugs (2018-2029)

    • Figure China Psoriasis and Atopic Dermatitis Drugs Sales Volume, Sales Value and Growth Rate of Online Pharmacies (2018-2029)

    • Figure China Psoriasis and Atopic Dermatitis Drugs Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)

    • Figure China Psoriasis and Atopic Dermatitis Drugs Sales Volume, Sales Value and Growth Rate of Retail Pharmacies (2018-2029)

    • Figure North China Psoriasis and Atopic Dermatitis Drugs Market Size and Growth Rate from 2018-2029

    • Figure Central China Psoriasis and Atopic Dermatitis Drugs Market Size and Growth Rate from 2018-2029

    • Figure South China Psoriasis and Atopic Dermatitis Drugs Market Size and Growth Rate from 2018-2029

    • Figure East China Psoriasis and Atopic Dermatitis Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Psoriasis and Atopic Dermatitis Drugs Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Psoriasis and Atopic Dermatitis Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Psoriasis and Atopic Dermatitis Drugs Market Size and Growth Rate from 2018-2029

    • Figure Psoriasis and Atopic Dermatitis Drugs Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Psoriasis and Atopic Dermatitis Drugs Market Share by Type in 2018

    • Figure China Psoriasis and Atopic Dermatitis Drugs Market Share by Type in 2023

    • Figure China Psoriasis and Atopic Dermatitis Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Psoriasis and Atopic Dermatitis Drugs Production Volume and Growth Rate of Psoriasis Drugs (2018-2023)

    • Figure China Psoriasis and Atopic Dermatitis Drugs Production Volume and Growth Rate of Atopic Dermatitis Drugs (2018-2023)

    • Figure China Psoriasis and Atopic Dermatitis Drugs Market Share by Application in 2018

    • Figure China Psoriasis and Atopic Dermatitis Drugs Market Share by Application in 2023

    • Figure China Psoriasis and Atopic Dermatitis Drugs Total Market Size and Growth Rate from Consumption End

    • Figure China Psoriasis and Atopic Dermatitis Drugs Market Size and Growth Rate of Online Pharmacies (2018-2023)

    • Figure China Psoriasis and Atopic Dermatitis Drugs Market Size and Growth Rate of Hospital Pharmacies (2018-2023)

    • Figure China Psoriasis and Atopic Dermatitis Drugs Market Size and Growth Rate of Retail Pharmacies (2018-2023)

    • Table China Psoriasis and Atopic Dermatitis Drugs Production Volume by Region (2018-2023)

    • Table China Psoriasis and Atopic Dermatitis Drugs Production Volume Share by Region (2018-2023)

    • Figure China Psoriasis and Atopic Dermatitis Drugs Production Volume Share by Region (2018-2023)

    • Table China Psoriasis and Atopic Dermatitis Drugs Production Value by Region (2018-2023)

    • Table China Psoriasis and Atopic Dermatitis Drugs Production Value Share by Region (2018-2023)

    • Figure China Psoriasis and Atopic Dermatitis Drugs Production Value Share by Region (2018-2023)

    • Table China Psoriasis and Atopic Dermatitis Drugs Sales Volume by Region (2018-2023)

    • Table China Psoriasis and Atopic Dermatitis Drugs Sales Volume Share by Region (2018-2023)

    • Figure China Psoriasis and Atopic Dermatitis Drugs Sales Volume Share by Region (2018-2023)

    • Table China Psoriasis and Atopic Dermatitis Drugs Sales Value by Region (2018-2023)

    • Table China Psoriasis and Atopic Dermatitis Drugs Sales Value Share by Region (2018-2023)

    • Figure China Psoriasis and Atopic Dermatitis Drugs Sales Value Share by Region (2018-2023)

    • Table North China Psoriasis and Atopic Dermatitis Drugs Production Volume by Type (2018-2023)

    • Table North China Psoriasis and Atopic Dermatitis Drugs Production Volume Share by Type (2018-2023)

    • Figure North China Psoriasis and Atopic Dermatitis Drugs Production Volume Share by Type (2018-2023)

    • Table North China Psoriasis and Atopic Dermatitis Drugs Sales Volume by Application (2018-2023)

    • Table North China Psoriasis and Atopic Dermatitis Drugs Sales Volume Share by Application (2018-2023)

    • Figure North China Psoriasis and Atopic Dermatitis Drugs Sales Volume Share by Application (2018-2023)

    • Table Central China Psoriasis and Atopic Dermatitis Drugs Production Volume by Type (2018-2023)

    • Table Central China Psoriasis and Atopic Dermatitis Drugs Production Volume Share by Type (2018-2023)

    • Figure Central China Psoriasis and Atopic Dermatitis Drugs Production Volume Share by Type (2018-2023)

    • Table Central China Psoriasis and Atopic Dermatitis Drugs Sales Volume by Application (2018-2023)

    • Table Central China Psoriasis and Atopic Dermatitis Drugs Sales Volume Share by Application (2018-2023)

    • Figure Central China Psoriasis and Atopic Dermatitis Drugs Sales Volume Share by Application (2018-2023)

    • Table South China Psoriasis and Atopic Dermatitis Drugs Production Volume by Type (2018-2023)

    • Table South China Psoriasis and Atopic Dermatitis Drugs Production Volume Share by Type (2018-2023)

    • Figure South China Psoriasis and Atopic Dermatitis Drugs Production Volume Share by Type (2018-2023)

    • Table South China Psoriasis and Atopic Dermatitis Drugs Sales Volume by Application (2018-2023)

    • Table South China Psoriasis and Atopic Dermatitis Drugs Sales Volume Share by Application (2018-2023)

    • Figure South China Psoriasis and Atopic Dermatitis Drugs Sales Volume Share by Application (2018-2023)

    • Table East China Psoriasis and Atopic Dermatitis Drugs Production Volume by Type (2018-2023)

    • Table East China Psoriasis and Atopic Dermatitis Drugs Production Volume Share by Type (2018-2023)

    • Figure East China Psoriasis and Atopic Dermatitis Drugs Production Volume Share by Type (2018-2023)

    • Table East China Psoriasis and Atopic Dermatitis Drugs Sales Volume by Application (2018-2023)

    • Table East China Psoriasis and Atopic Dermatitis Drugs Sales Volume Share by Application (2018-2023)

    • Figure East China Psoriasis and Atopic Dermatitis Drugs Sales Volume Share by Application (2018-2023)

    • Table Northeast China Psoriasis and Atopic Dermatitis Drugs Production Volume by Type (2018-2023)

    • Table Northeast China Psoriasis and Atopic Dermatitis Drugs Production Volume Share by Type (2018-2023)

    • Figure Northeast China Psoriasis and Atopic Dermatitis Drugs Production Volume Share by Type (2018-2023)

    • Table Northeast China Psoriasis and Atopic Dermatitis Drugs Sales Volume by Application (2018-2023)

    • Table Northeast China Psoriasis and Atopic Dermatitis Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Psoriasis and Atopic Dermatitis Drugs Sales Volume Share by Application (2018-2023)

    • Table Southwest China Psoriasis and Atopic Dermatitis Drugs Production Volume by Type (2018-2023)

    • Table Southwest China Psoriasis and Atopic Dermatitis Drugs Production Volume Share by Type (2018-2023)

    • Figure Southwest China Psoriasis and Atopic Dermatitis Drugs Production Volume Share by Type (2018-2023)

    • Table Southwest China Psoriasis and Atopic Dermatitis Drugs Sales Volume by Application (2018-2023)

    • Table Southwest China Psoriasis and Atopic Dermatitis Drugs Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Psoriasis and Atopic Dermatitis Drugs Sales Volume Share by Application (2018-2023)

    • Table Northwest China Psoriasis and Atopic Dermatitis Drugs Production Volume by Type (2018-2023)

    • Table Northwest China Psoriasis and Atopic Dermatitis Drugs Production Volume Share by Type (2018-2023)

    • Figure Northwest China Psoriasis and Atopic Dermatitis Drugs Production Volume Share by Type (2018-2023)

    • Table Northwest China Psoriasis and Atopic Dermatitis Drugs Sales Volume by Application (2018-2023)

    • Table Northwest China Psoriasis and Atopic Dermatitis Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Psoriasis and Atopic Dermatitis Drugs Sales Volume Share by Application (2018-2023)

    • Table Allergan Plc Company Profile

    • Table Allergan Plc Psoriasis and Atopic Dermatitis Drugs Revenue, Price and Gross (2018-2023)

    • Table Regeneron Pharmaceuticals, Inc Company Profile

    • Table Regeneron Pharmaceuticals, Inc Psoriasis and Atopic Dermatitis Drugs Revenue, Price and Gross (2018-2023)

    • Table Leo Pharma Company Profile

    • Table Leo Pharma Psoriasis and Atopic Dermatitis Drugs Revenue, Price and Gross (2018-2023)

    • Table Incyte Company Profile

    • Table Incyte Psoriasis and Atopic Dermatitis Drugs Revenue, Price and Gross (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer Psoriasis and Atopic Dermatitis Drugs Revenue, Price and Gross (2018-2023)

    • Table Valent Pharmaceutical Inc Company Profile

    • Table Valent Pharmaceutical Inc Psoriasis and Atopic Dermatitis Drugs Revenue, Price and Gross (2018-2023)

    • Table Mylan Company Profile

    • Table Mylan Psoriasis and Atopic Dermatitis Drugs Revenue, Price and Gross (2018-2023)

    • Table Bristol-Myers Squibb Company Company Profile

    • Table Bristol-Myers Squibb Company Psoriasis and Atopic Dermatitis Drugs Revenue, Price and Gross (2018-2023)

    • Table Sanofi Company Profile

    • Table Sanofi Psoriasis and Atopic Dermatitis Drugs Revenue, Price and Gross (2018-2023)

    • Table Bayer AG Company Profile

    • Table Bayer AG Psoriasis and Atopic Dermatitis Drugs Revenue, Price and Gross (2018-2023)

    • Table Novartis International AG Company Profile

    • Table Novartis International AG Psoriasis and Atopic Dermatitis Drugs Revenue, Price and Gross (2018-2023)

    • Table Anacor Pharmaceutical Inc Company Profile

    • Table Anacor Pharmaceutical Inc Psoriasis and Atopic Dermatitis Drugs Revenue, Price and Gross (2018-2023)

    • Table Encore Dermatology Company Profile

    • Table Encore Dermatology Psoriasis and Atopic Dermatitis Drugs Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US